Results 51 to 60 of about 4,474 (198)

Transcatheter closure of Ventricular Septal defects in Malta : initial experience [PDF]

open access: yes, 2005
Ventricular septal defects (VSD) consist of deficiencies of the wall separating the two ventricles. VSDs are the commonest congenital cardiac defects. Small VSDs rarely require intervention, however, larger defects cause ventricular volume overload with ...
Aquilina, Oscar   +6 more
core  

Hemolysis induced by PMIVSD occluder

open access: yesIndian Heart Journal, 2016
Hemolysis related to occluder, prosthetic valve, and prosthetic ring used for mitral valve annuloplasty are not very unusual. However, hemolysis related to transcathetor closure of post-myocardial infarction ventricular septal defect (PMIVSD) is ...
D. Sheshagiri Rao   +2 more
doaj   +1 more source

Haemolysis after Amplatzer device closure of ventricular septal defect [PDF]

open access: yes, 2007
Over the last few years, a vast variety of devices have been developed to close various septal defects through the transcatheter route. Haemolysis has been documented after Amplatzer device closure of patent ductus arteriousus, atrial septal defect ...
Mulvaney, Shirley, Grech, Victor E.
core  

Successful percutaneous closure of a residual atrial septal defect due to device failure

open access: yesRevista Portuguesa de Cardiologia, 2017
A 39-year-old woman underwent uneventful percutaneous occlusion of an ostium secundum atrial septal defect (ASD) with a 22 mm Ultrasept ASD Occluder®.
Sílvia Aguiar Rosa   +9 more
doaj   +1 more source

Transcatheter closure of symptomatic aortopulmonary window in an infant [PDF]

open access: yes, 2008
An aortopulmonary window is a rare congenital cardiac defect. In the majority of symptomatic neonates and infants, primary surgical repair is the treatment of choice.
Brockmeier, Konrad   +4 more
core  

Adaptive 4D‐Printed Vascular Stents With Low‐Temperature‐Activated and Intelligent Deployment

open access: yesAdvanced Functional Materials, Volume 36, Issue 27, 2 April 2026.
Microarchitected coronary artery stents were fabricated using a polycaprolactone (PCL)‐based shape memory polymer (SMP) composite via projection micro‐stereolithography (PµSL) 4D printing. By incorporating diethyl phthalate (DEP) as a plasticizer, the thermal transition temperature (Ttran) was modulated to about 37°C, enabling rapid and autonomous ...
Yannan Li   +12 more
wiley   +1 more source

Transcatheter Closure of Atrial Septal Defect with Carag Bioresorbable Septal Occluder™: First-in-Child Experience with 12-MonthFollow-Up

open access: yesJournal of Interventional Cardiology, 2022
Background. Nowadays, transcatheter device closure of an atrial septal defect (ASD) is a standard approach in children. Potential early and long-term side effects or complications related to the metal framework of the devices are a known issue.
Alessia Callegari   +6 more
doaj   +1 more source

Comparison of long-term complications of using amplatzer ductal occluder and ventricular septal defect occluder for transcatheter ventricular septal defect closure

open access: yesHeart Views, 2021
Background: Ventricular Septal Defect (VSD) is the most common type of congenital heart disease and perimembranous type is the commonest form of these defects. Trans-catheter management of these defects is a challenging procedure. Objectives: The purpose
Mehdi Ghaderian, Negin Salemi
doaj   +1 more source

New Right‐To‐Left Shunt Through a Patent Foramen Ovale Following Abdominal Surgery

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT In the setting of new platypnea‐orthodeoxia syndrome, early consideration of right‐to‐left shunting via a patent foramen ovale is critical for effective management.
Jack Franke   +5 more
wiley   +1 more source

Late endocarditis of amplatzer atrial septal occluder device in a child

open access: yesWorld Journal of Cardiology, 2015
Bacterial endocarditis following atrial septal defect closure using Amplatzer device in a child is extremely rare. We report a 10-year-old girl who developed late bacterial endocarditis, 6 years after placement of an Amplatzer atrial septal occluder device.
Neerod K, Jha   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy